跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 68 条关于
“CD16a”
全部
68
临床试验
26
药物
22
机构
0
资讯
20
10个月前
Novel Monoclonal Antibody F9H4 Prevents CD16a/b Shedding to Enhance NK Cell-Mediated Cancer Immunotherapy
3年前
Margetuximab Shows Promise as Alternative Therapy in HER2-Positive Advanced Breast Cancer
3年前
Margetuximab Fails to Show Overall Survival Benefit Over Trastuzumab in HER2-Positive Breast Cancer
2年前
Expanding Treatment Options for HER2+ Breast Cancer Patients
4年前
Margetuximab Not Cost-Effective Compared to Trastuzumab for ERBB2-Positive Advanced Breast Cancer
7个月前
NK Cell Engager Development Faces Mounting Setbacks as BeOne Medicines and Novartis Discontinue Programs
去年
Affimed Advances in Innate Cell Engager Therapies for Cancer Treatment
去年
Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in Relapsed/Refractory Acute Myeloid Leukemia
去年
Affimed N.V. Advances in Clinical Development of Novel Therapies for Solid and Liquid Tumors
2年前
CAR-NK Cell Therapy Shows Promise as Safer Alternative to CAR-T with Comparable Efficacy in Early Clinical Trials
第 1 页,共 2 页
上一页
下一页